p-hydroxyamphetamine has been researched along with Cerebrovascular Disorders in 1 studies
p-Hydroxyamphetamine: Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keane, JR | 1 |
1 other study available for p-hydroxyamphetamine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Oculosympathetic paresis. Analysis of 100 hospitalized patients.
Topics: Adolescent; Adult; Aged; Autonomic Fibers, Postganglionic; Autonomic Fibers, Preganglionic; Cerebrov | 1979 |